Pharma - Q3FY23 - Earnings Preview
Low single-digit growth in the US market (due to intense competition) and low double-digit growth in the India business after Covid-19 business has...
451 Views
Pharma Q2fy23 Preview
The Pharma universe under our coverage could report aggregate Revenue/EBITDA/PAT growth of 5.6%/-4.8%/-2.2% YoY. Currency (Rs) has depreciated by 5.0%
263 Views
Profit from India's Rapidly Growing Biotechnology Industry
Now is a strategic time to focus on the upside potential of biotechnology companies in India, as Indiaās biotechnology industry is projected to...
5.1k Views
India's Budgets: 2006-2015. Key Charts, and Key questions
In continuation of my work of detailed work on India Budget for last ten years, this piece through simple charts puts in perspective: Ā 2014 Actual...
557 Views
Aarti Drugs Ltd - Margin Gains & Expansion Plans Fuel Optimism for H2
Aarti Drugs reported revenue of Rs 591 Cr, marginally below our estimate of Rs 598 Cr, yet broadly in line with expectations. Revenue grew by 6.3%...
234 Views